论文部分内容阅读
Objectives:To evaluate the clinical effectivenessand toxicity of adjuvant Kanglaite(KLT)injection in elderly patients receiving induction chemotherapy for AML(non-APL).Methods: A retrospective clinical study was conducted in elderly AML patients aged 60 years and above in Dongzhimen Hospital from January 2009 to January 2016.Based on whether KLT injection was incorporated into the treatment regimen,qualified cases were divided into two groups: those who received KLT injection(combined treatment group)and those who did not(simple treatment group).